Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-8448b6f56d-c4f8m Total loading time: 0 Render date: 2024-04-25T06:21:36.376Z Has data issue: false hasContentIssue false

7 - Psychosis and Its Treatment

Published online by Cambridge University Press:  22 July 2022

Stephen M. Stahl
Stephen M. Stahl
Affiliation:
University of California, San Diego
Get access

Summary

A 24-year-old male initially presents with acute auditory hallucinations and is treated with medication. Four days later he arrives at your office for evaluation. You observe that he is neatly dressed, avoids eye contact, and gives very short answers to your initial questions. Which of the following questions would be most beneficial for determining his degree of negative symptoms?

Type
Chapter
Information
Stahl's Self-Assessment Examination in Psychiatry
Multiple Choice Questions for Clinicians
 , pp. 207 - 262
Publisher: Cambridge University Press
Print publication year: 2022

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References

Stahl, SM. Stahl’s essential psychopharmacology, fifth edition. New York, NY: Cambridge University Press; 2021. (Chapter 4)Google Scholar
Stahl, SM, Buckley, PF. Negative symptoms of schizophrenia: a problem that will not go away. Acta Psychiatr Scand 2007;15:4–11.Google Scholar

References

Insel, TR. Rethinking schizophrenia. Nature 2010;468:187–93.Google Scholar
McGorry, PD, Yung, AR, Bechdolf, A, Amminger, P. Back to the future: predicting and reshaping the course of psychotic disorder. Arch Gen Psychiatry 2008;65:25–7.CrossRefGoogle Scholar

Reference

Stahl, SM. Stahl’s essential psychopharmacology, fifth edition. New York, NY: Cambridge University Press; 2021. (Chapter 4)CrossRefGoogle Scholar

Reference

Stahl, SM. Stahl’s essential psychopharmacology, fifth edition. New York, NY: Cambridge University Press; 2021. (Chapter 4)Google Scholar

Reference

Stahl, SM. Stahl’s essential psychopharmacology, fifth edition. New York, NY: Cambridge University Press; 2021. (Chapter 5)Google Scholar

Reference

Morrisette, DM, Stahl, SM. Treating the violent patient with psychosis or impulsivity utilizing antipsychotic polypharmacy and high-dose monotherapy. CNS Spectr 2014;19(5):439–48.Google Scholar

References

Stahl, SM. Essential psychopharmacology, the prescriber’s guide, seventh edition. New York, NY: Cambridge University Press; 2020.Google Scholar
Stahl, SM. Stahl’s essential psychopharmacology, fifth edition. New York, NY: Cambridge University Press; 2021. (Chapter 5)Google Scholar

References

Roth, BL. Ki determinations, receptor binding profiles, agonist and/or antagonist functional data, HERG data, MDR1 data, etc. as appropriate was generously provided by the National Institute of Mental Health’s Psychoactive Drug Screening Program, Contract # HHSN-271–2008–00025-C (NIMH PDSP). The NIMH PDSP is directed by Bryan L. Roth, MD, PhD at the University of North Carolina at Chapel Hill and Project Officer Jamie Driscol at NIMH, Bethesda, MD, USA. For experimental details please refer to the PDSP website http://pdsp.med.unc.edu.Google Scholar
Stahl, SM. Stahl’s essential psychopharmacology, fifth edition. New York, NY: Cambridge University Press; 2021. (Chapter 5)Google Scholar

Reference

Stahl, SM. Stahl’s essential psychopharmacology, fifth edition. New York, NY: Cambridge University Press; 2021. (Chapter 5)Google Scholar

References

Stahl, SM. Mechanism of action of brexpiprazole: comparison with aripiprazole. CNS Spectr 2016;21:1–6.CrossRefGoogle ScholarPubMed
Stahl, SM. Mechanism of action of cariprazine. CNS Spectr 2016;21:123–7.Google Scholar

References

Lohr, JB, Eidt, CA, Abdulrazzaq Alfaraj, A, Soliman, MA. The clinical challenges of akathisia. CNS Spectr 2015;20:4–14.CrossRefGoogle ScholarPubMed
Stahl, SM, Loonen, AJ. The mechanism of drug-induced akathisia. CNS Spectr 2011;16(1):7–10.Google Scholar

References

Fernandez, HH, Factor, SA, Hauser, RA et al. Randomized controlled trial of deutetrabenazine for tardive dyskinesia: the ARM-TD study. Neurology 2017;88(21):2003–10.Google Scholar
Hauser, RA, Factor, SA, Marder, SR et al. KINECT 3: a phase 3 randomized, double-blind, placebo-controlled trial of valbenazine for tardive dyskinesia. Am J Psychiatry 2017;174(5):476–84.Google Scholar
Waln, O, Jankovic, J. An update on tardive dyskinesia: from phenomenology to treatment. Tremor Other Hyperkinet Mov (N Y) 2013;3:tre-03-161-4138-1. doi:10.7916/D88P5Z71.Google ScholarPubMed

References

Stahl, SM. Essential psychopharmacology, the prescriber’s guide, seventh edition. New York, NY: Cambridge University Press; 2020.Google Scholar
Stahl, SM. Stahl’s essential psychopharmacology, fifth edition. New York, NY: Cambridge University Press; 2021. (Chapter 5)Google Scholar

References

Stahl, SM. Essential psychopharmacology, the prescriber’s guide, seventh edition. New York, NY: Cambridge University Press; 2020.Google Scholar
Stahl, SM. Stahl’s essential psychopharmacology, fifth edition. New York, NY: Cambridge University Press; 2021. (Chapter 5)Google Scholar

References

Maroney, M. An update on the current treatment strategies and emerging agents for the management of schizophrenia. Am J Manag Care 2020;26(3 Suppl): S55–61.Google Scholar
Stahl, SM. Case studies: Stahl’s essential psychopharmacology. New York, NY: Cambridge University Press; 2011.CrossRefGoogle Scholar
Stahl, SM. Essential psychopharmacology, the prescriber’s guide, seventh edition. New York, NY: Cambridge University Press; 2017.Google Scholar
Stahl, SM. Stahl’s essential psychopharmacology, fifth edition. New York, NY: Cambridge University Press; 2021. (Chapter 5)Google Scholar

References

Stahl, SM. Essential psychopharmacology, the prescriber’s guide, seventh edition. New York, NY: Cambridge University Press; 2017.Google Scholar
Stahl, SM. Stahl’s essential psychopharmacology, fifth edition. New York, NY: Cambridge University Press; 2021. (Chapter 5)Google Scholar

References

Pandurangi, AK, Dalkilic, A. Polypharmacy with second-generation antipsychotics: a review of evidence. J Psychiatr Pract 2008;14:345.Google Scholar
Royal College of Psychiatrists. CR138. Consensus Statement on High-Dose Antipsychotic Medication. 2006. Available at: www.rcpsych.ac.uk/docs/default-source/members/faculties/rehabilitation-and-social-psychiatry/rehab-cr190.pdf?sfvrsn=d8397218_4.Google Scholar
Stahl, SM. Essential psychopharmacology, the prescriber’s guide, seventh edition. New York, NY: Cambridge University Press; 2020.CrossRefGoogle Scholar

References

Roth, BL. Ki determinations, receptor binding profiles, agonist and/or antagonist functional data, HERG data, MDR1 data, etc. as appropriate was generously provided by the National Institute of Mental Health’s Psychoactive Drug Screening Program, Contract # HHSN-271–2008–00025-C (NIMH PDSP). The NIMH PDSP is directed by Bryan L. Roth, MD, PhD at the University of North Carolina at Chapel Hill and Project Officer Jamie Driscol at NIMH, Bethesda, MD, USA. For experimental details please refer to the PDSP website http://pdsp.med.unc.edu.Google Scholar
Santana, N, Mengod, G, Artigas, F. Expression of alpha 1-adrenergic receptors in rat prefrontal cortex: cellular co-localization with 5-HT2A receptors. Int J Neuropsychopharmacol 2013;16(5):1139–51.Google Scholar
Stahl, SM. Stahl’s essential psychopharmacology, fifth edition. New York, NY: Cambridge University Press; 2021. (Chapter 5)Google Scholar

References

Neuroscience Education Institute. Recommended ANC monitoring [pdf]. 2017.Google Scholar
Stahl, SM. Essential psychopharmacology, the prescriber’s guide, seventh edition. New York, NY: Cambridge University Press; 2020.Google Scholar

References

Stahl, SM. Essential psychopharmacology, the prescriber’s guide, seventh edition. New York, NY: Cambridge University Press; 2017.Google Scholar
Stahl, SM. Stahl’s essential psychopharmacology, fifth edition. New York, NY: Cambridge University Press; 2021. (Chapter 5)Google Scholar

References

Meyer, JM. Converting oral to long-acting injectable antipsychotics: a guide for the perplexed. CNS Spectr 2017;22(Suppl):17–27.Google Scholar
Spanarello, S, La Ferla, T. The pharmacokinetics of long-acting antipsychotic medications. Curr Clin Pharmacol 2014;9(3):310–17.Google Scholar

Reference

Stahl, SM. Stahl’s essential psychopharmacology, fifth edition. New York, NY: Cambridge University Press; 2021. (Chapter 5)Google Scholar

References

Krogmann, A, Peters, L, von Hardenberg, L et al. Keeping up with the therapeutic advances in schizophrenia: a review of novel and emerging pharmacological entities. CNS Spectr 2019;24(S1):38–69.Google Scholar
Maroney, M. An update on the current treatment strategies and emerging agents for the management of schizophrenia. Am J Manag Care 2020;26(3 Suppl):S55–61.Google Scholar
Muly, EC, Votaw, JR, Ritchie, J, Howell, LL. Relationship between dose, drug levels, and D2 receptor occupancy for the atypical antipsychotics risperidone and paliperidone. J Pharmacol Exp Ther 2012;341(1):81–9.Google Scholar
Snyder, GL, Vanover, KE, Hongwen, Z et al. Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission. Psychopharmacology (Berl) 2015;232(3):605–21.CrossRefGoogle ScholarPubMed

References

Maroney, M. An update on the current treatment strategies and emerging agents for the management of schizophrenia. Am J Manag Care 2020;26(3 Suppl): S55–61.Google Scholar
Stahl, SM. Essential psychopharmacology, the prescriber’s guide, seventh edition. New York, NY: Cambridge University Press; 2020.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Psychosis and Its Treatment
  • Stephen M. Stahl, University of California, San Diego
  • Book: Stahl's Self-Assessment Examination in Psychiatry
  • Online publication: 22 July 2022
  • Chapter DOI: https://doi.org/10.1017/9781009241595.009
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Psychosis and Its Treatment
  • Stephen M. Stahl, University of California, San Diego
  • Book: Stahl's Self-Assessment Examination in Psychiatry
  • Online publication: 22 July 2022
  • Chapter DOI: https://doi.org/10.1017/9781009241595.009
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Psychosis and Its Treatment
  • Stephen M. Stahl, University of California, San Diego
  • Book: Stahl's Self-Assessment Examination in Psychiatry
  • Online publication: 22 July 2022
  • Chapter DOI: https://doi.org/10.1017/9781009241595.009
Available formats
×